NEVVI Medicare utilization intelligence

← back

TIBAYAN, RESTYMD NPI 1508029208 Clinician

Hematology-Oncology · HENDERSON, NV

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 28 years since medical school (class of 1998, self-reported to CMS)
Location HENDERSON, NV · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 72 codes billed · 150,215 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
ALLISON CURTIS KINGSLEY MEOZ MICHAEL AND SANCHEZ PC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2024-03

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
J1453 Injection, fosaprepitant, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1449 Injection, eflapegrastim-xnst, 0.1 mg
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J9395 Injection, fulvestrant, 25 mg
36415 Insertion of needle into vein for collection of blood sample
J2469 Injection, palonosetron hcl, 25 mcg
80053 Blood test, comprehensive group of blood chemicals
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J0640 Injection, leucovorin calcium, per 50 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
82746 Folic acid level, serum
J1626 Injection, granisetron hydrochloride, 100 mcg
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
82607 Cyanocobalamin (vitamin b-12) level
96375 Injection of additional new drug or substance into vein
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96372 Injection of drug or substance under skin or into muscle
82784 Gammaglobulin (immune system protein) measurement
J9190 Injection, fluorouracil, 500 mg
96413 Administration of chemotherapy into vein, 1 hour or less
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
82306 Vitamin d-3 level
J9045 Injection, carboplatin, 50 mg
83615 Lactate dehydrogenase (enzyme) level
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
J1200 Injection, diphenhydramine hcl, up to 50 mg
J3489 Injection, zoledronic acid, 1 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
84165 Protein measurement, serum
86334 Immunologic analysis technique on serum (immunofixation)
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
82378 Carcinoembryonic antigen (cea) protein level
96417 Administration of additional new drug or substance into vein, 1 hour or less
96374 Injection of drug or substance into vein
83521 Measurement of immunoglobulin light chains
82232 Beta-2 microglobulin (protein) level
J7030 Infusion, normal saline solution , 1000 cc
83883 Nephelometry, test method using light
86140 Measurement c-reactive protein for detection of infection or inflammation
J3490 Unclassified drugs
96360 Infusion into a vein for hydration, 31-60 minutes
85652 Red blood cell sedimentation rate, to detect inflammation, automated
96361 Infusion into a vein for hydration, each additional hour
96415 Administration of chemotherapy into vein, each additional hour
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
84100 Phosphate level
96411 Administration of additional new drug or substance into vein using push technique
85045 Red blood count, automated test
83010 Haptoglobin (serum protein) level
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
84443 Blood test, thyroid stimulating hormone (tsh)
84481 Thyroid hormone, t3 measurement, free
84439 Thyroxine (thyroid chemical), free
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
83735 Magnesium level
84153 Psa (prostate specific antigen) measurement, total
84550 Uric acid level, blood
84403 Testosterone (hormone) level, total
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
81000 Manual urinalysis test with examination using microscope, non-automated
96523 Irrigation of implanted venous access drug delivery device

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.